Skip to main content
Signal8
Quirk Gerald E profile photo

Gerald E. Quirk

CIK: 0001479603

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Syros Pharmaceuticals, Inc. logo
SYRS

Syros Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Nov 19, 2024
    Sale(S)
    Direct
    46.7K shares at avg. $0.22$10K
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Sep 30, 2024
    Exercise(M)
    Direct
    10K shares-
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Sep 30, 2024
    Tax Payment(F)
    Direct
    3.1K shares at avg. $2.10$7K

1-3 of 3

Gerald E. Quirk files insider reports with the SEC as Chief Legal & Compliance Offic of Syros Pharmaceuticals, Inc. (SYRS). Signal8 holds 3 reported Form 4/5 transactions by Gerald E. Quirk since Sep 2024. The most recent reported transaction is a sale (Form 4 code S) in SYRS, dated Nov 19, 2024.

About Quirk Gerald E

Quirk Gerald E (SEC CIK 0001479603) files insider reports with the SEC as Chief Legal & Compliance Offic of Syros Pharmaceuticals, Inc. (SYRS).

Signal8 holds 2 ownership filings by Quirk Gerald E, all Form 4s, filed between Oct 2, 2024 and Nov 20, 2024. Those filings report 3 transactions, from Sep 30, 2024 to Nov 19, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Quirk Gerald E's filings is in CAMBRIDGE, MA.

Recent filings by Quirk Gerald E

  • Nov 19, 2024: Open-market sale of SYRS shares (Form 4, code S).
  • Sep 30, 2024: Option exercise of SYRS shares (Form 4, code M).
  • Sep 30, 2024: Tax withholding of SYRS shares (Form 4, code F).

Other insiders filing for Syros Pharmaceuticals, Inc. (SYRS)

How to read Form 4 transaction codes